Gene Set Enrichment Analysis (GSEA) based Aging related Biological Pathway & Process Identification Service
Creative Biolabs solves the fundamental problem of aging research network noise by moving beyond traditional differential expression analysis (DEA) to use GSEA. This approach isolates the coordinated failure of entire biological circuits by analyzing the whole transcriptome, prioritizing targets that destabilize crucial homeostatic networks. Our core capability is transforming raw data into a clear mechanism of action hypothesis, identifying the leading-edge subset—the most pivotal genes responsible for a pathway's statistical shift—to provide a focused list of the highest-confidence therapeutic targets, reducing costs.
Background Workflow Why Choose Us FAQs Customer Review Related Services Contact Us
GSEA: The Gold Standard for Systems-Level Pathway Discovery
GSEA is a powerful, non-parametric method that determines whether a predefined gene set (representing a biological pathway) shows statistically significant, concordant differences between two states (e.g., young vs. aged). Unlike traditional DEA, which focuses on fragmented lists of individual genes exceeding an arbitrary threshold, GSEA utilizes all genes ranked by expression change. This approach increases sensitivity, provides functionally integrated pathways rather than low signal-to-noise gene lists, and shifts the value proposition from identifying mere biomarkers to isolating actionable therapeutic targets and master regulatory processes.
Discover How Creative Biolabs Can Help - Request a Consultation Today to Discuss Your Data.
Workflow: Precision Mapping of Aging Pathways
Our GSEA workflow is a highly structured, validated five-step process designed to eliminate guesswork and maximize actionable outputs.
Why Choose Us?
With over two decades dedicated to complex biological analysis, Creative Biolabs is not just a service provider; we are a strategic partner in your longevity research. Our scientific acumen ensures that the insights you receive are not only statistically sound but also commercially relevant.
The Creative Biolabs' advantage:
20+ Years of Specialization
This allows us to interpret GSEA results within the context of the hallmarks of aging, ensuring that identified targets are not just statistically significant but are also validated as core longevity drivers in the scientific literature.
Rigorous Statistical Framework
We employ a rigorous statistical approach, including phenotype-based permutation testing and false discovery rate (FDR) control, specifically optimized for the high complexity and inter-sample variability of aging datasets.
Actionable MoA Hypothesis
We transform complex data into a clear mechanism of action (MoA) hypothesis, detailing how the identified targets correct pathway failure to ensure a rational drug development strategy.
Target-to-Clinic Focus
We prioritize data presentation to meet IND-enabling criteria, providing clear recommendations on therapeutic modality, target tractability, and predicted safety liabilities, ensuring a seamless transition from discovery to the preclinical pipeline.
Experience the Creative Biolabs Advantage - Get a Quote Today and validate your next therapeutic target.
FAQs
Q1: Can your service handle single-cell RNA-Seq (scRNA-seq) data, and what are the advantages?
A1: Yes, we utilize single-sample GSEA (ssGSEA) for scRNA-seq. This provides unmatched cellular resolution, allowing you to track aging trajectories and network destabilization in specific, rare cell populations, which is critical for understanding systemic aging.
Q2: How do you ensure the gene sets are relevant to longevity research?
A2: We go beyond standard public databases. We employ proprietary, meticulously curated gene sets focused specifically on the established hallmarks of aging. This specialization ensures the highest commercial and biological relevance for identifying genuine anti-aging targets.
Q3: I have data from other platforms (proteomics/metabolomics). Can that be integrated?
A3: Absolutely. While GSEA is primarily transcriptomic, Creative Biolabs specializes in multi-omic integration. We can use your non-transcriptomic data to filter and prioritize the final pathway list, ensuring your selected gene targets align with functional changes observed across all omic layers.
Customer Review
-
Exceptional Sensitivity
Using Creative Biolabs' service in our research has significantly facilitated the detection of subtle, coordinated changes in mitochondrial function pathways that we routinely missed with traditional DEA. – Dr. Jne*Ln
-
Validated Approach
The strong correlation between our protein findings and their GSEA pathway results (targeting proteostasis network failure) provided the systems-level evidence needed to secure phase I funding. – Cy*Ro
Related Services
To fully leverage the systems-level insights from our GSEA analysis, Creative Biolabs offers several complementary services:
NGS based Genome Sequencing Service
Creative Biolabs offers complete, high-throughput next-generation sequencing (NGS) solutions for cancer genomics and treatment, leveraging specialists in bioinformatics and molecular biology for proven, high-quality insights.
Learn More →
Kinase Target Screening Services
Protein kinases are critical drug targets for cancer and inflammation. Creative Biolabs provides comprehensive kinase target screening to understand compound selectivity and MOA, accelerating development.
Learn More →
How to Contact Creative Biolabs
Creative Biolabs' GSEA based aging related biological pathway & process identification service provides the systems-level clarity required to navigate the complexity of aging genomics. We convert your raw transcriptomic data into a prioritized list of functionally validated therapeutic targets, driving the next generation of longevity drug discovery.
Do not allow the complexity of aging research to stall your drug discovery efforts. Reach out to our expert team today to schedule a confidential discussion about your specific project needs and data challenges.
